Showing results (31-40 of 136) with videos related to
Sort By:
Pageof 14
Plos One|April 13, 2018
Correction: Dissecting the Autocrine and Paracrine Roles of the CCR2-CCL2 Axis in Tumor Survival and AngiogenesisLiat Izhak, Gizi Wildbaum, Steffen Jung, et al.Molecular & Cellular Proteomics : MCP|January 28, 2015
Proteomics of microparticles with SILAC Quantification (PROMIS-Quan): a novel proteomic method for plasma biomarker quantificationMichal Harel, Pazit Oren-Giladi, Orit Kaidar-Person, et al.Oncogene|January 24, 2019
ATF3 and JDP2 deficiency in cancer associated fibroblasts promotes tumor growth via SDF-1 transcriptionShimrit Avraham, Ben Korin, Sharon Aviram, et al.Plos One|January 27, 2012
Dissecting the autocrine and paracrine roles of the CCR2-CCL2 axis in tumor survival and angiogenesisLiat Izhak, Gizi Wildbaum, Steffen Jung, et al.Current Clinical Pharmacology|April 22, 2010
Vascular disrupting agents (VDAs) in anticancer therapyLaura G M Daenen, Jeanine M L Roodhart, Yuval Shaked, et al.Breast (Edinburgh, Scotland)|October 4, 2005
Anti-angiogenic treatment of breast cancer using metronomic low-dose chemotherapyRaquel Munoz, Yuval Shaked, Francesco Bertolini, et al.Bio-Protocol|February 12, 2026
The Generation of Tissue-Specific ECM Hydrogels From Melanoma and Associated Organs to Study Cancer BiologyYuval Mogilevsky, Chen Sharon-Yagol, Bar Manobla, et al.Iscience|August 18, 2025
Immature monocytic cells within tumors differentiate into immunosuppressive cells in resistant tumors to immunotherapySapir Levin, Madeleine Benguigui, Bar Manobla, et al.Oncotarget|February 9, 2018
Dose- and time-dependence of the host-mediated response to paclitaxel therapy: a mathematical modeling approachMadeleine Benguigui, Dror Alishekevitz, Michael Timaner, et al.Cancer Research|April 19, 2007
Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumorsChris Folkins, Shan Man, Ping Xu, et al.Pageof 14